Search Tag: personalised and precision medicine
2015 10 Aug
The U.S. Food and Drug Administration has approved the first 3D-printed drug, SPRITAM ® , for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalised tonic-clonic seizures in adults and children with epilepsy. The FDA approval is being hailed as a breakthrough in precision...Read more
2015 10 May
According to Dr Victor Dzau, President of the U.S. Institute of Medicine and colleagues, new developments in personalised and precision medicine (PPM) could offer significant gains in healthy life expectancy for Americans but the incentives to develop them are weak. The personal view has been published in The Lancet. PPM is tailored medical treatment...Read more